Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA
Sam Gandy, David S. Knopman, Mary Sano
Topics & Concepts
MedicineNeurologyAlternative medicineDrug approvalIntensive care medicineFamily medicinePharmacologyPsychiatryPathologyDrugEpilepsy research and treatmentDementia and Cognitive Impairment ResearchHealthcare Decision-Making and Restraints